Ravindran S, Ranganathan S, R K, J N, A S, Kannan S
J Liq Biopsy. 2025; 7:100285.
PMID: 40027232
PMC: 11863969.
DOI: 10.1016/j.jlb.2025.100285.
Devaraja K, Aggarwal S
Biomedicines. 2025; 13(2).
PMID: 40002861
PMC: 11852717.
DOI: 10.3390/biomedicines13020448.
Lopez-Ansio M, Ramos-Garcia P, Gonzalez-Moles M
Cancers (Basel). 2025; 17(2).
PMID: 39858110
PMC: 11764026.
DOI: 10.3390/cancers17020329.
Mohd Faizal N, Vincent-Chong V, Ramanathan A, Paterson I, Karen-Ng L, Zaini Z
Biomedicines. 2025; 12(12.
PMID: 39767805
PMC: 11726734.
DOI: 10.3390/biomedicines12122899.
Bilger A, Lambert P
Tumour Virus Res. 2025; 19:200312.
PMID: 39755235
PMC: 11764593.
DOI: 10.1016/j.tvr.2024.200312.
Clinical Management Update of Oral Leukoplakia: A Review From the American Head and Neck Society Cancer Prevention Service.
Gates J, Abouyared M, Shnayder Y, Farwell D, Day A, Alawi F
Head Neck. 2024; 47(2):733-741.
PMID: 39584361
PMC: 11717973.
DOI: 10.1002/hed.28013.
Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cells.
Holzmann K, Wolf J, Stangl S, Lennartz P, Kasajima A, Mogler C
Br J Cancer. 2024; 131(11):1814-1824.
PMID: 39406917
PMC: 11589746.
DOI: 10.1038/s41416-024-02872-8.
Reconstructing oral cavity tumor evolution through brush biopsy.
John E, Lesluyes T, Baker T, Tarabichi M, Gillenwater A, Wang J
Sci Rep. 2024; 14(1):22591.
PMID: 39343812
PMC: 11439926.
DOI: 10.1038/s41598-024-72946-3.
Genomic alterations in the stepwise progression from normal mucosa to metastasizing oral squamous cell carcinoma.
Jensen J, Sjostedt S, Carmona J, Ahlborn L, Vieira F, Nielsen F
Front Oncol. 2024; 14:1450361.
PMID: 39324009
PMC: 11422351.
DOI: 10.3389/fonc.2024.1450361.
A Transcriptomic Analysis of Laryngeal Dysplasia.
Maffini F, Lepanto D, Chu F, Tagliabue M, Vacirca D, De Berardinis R
Int J Mol Sci. 2024; 25(17).
PMID: 39273632
PMC: 11395940.
DOI: 10.3390/ijms25179685.
Identification of genomic alteration and prognosis using pathomics-based artificial intelligence in oral leukoplakia and head and neck squamous cell carcinoma: a multicenter experimental study.
Cai X, Peng C, Cui Y, Li L, Huang M, Zhang H
Int J Surg. 2024; 111(1):426-438.
PMID: 39248300
PMC: 11745750.
DOI: 10.1097/JS9.0000000000002077.
Head and neck cancer: pathogenesis and targeted therapy.
Liu Y, Zhang N, Wen Y, Wen J
MedComm (2020). 2024; 5(9):e702.
PMID: 39170944
PMC: 11338281.
DOI: 10.1002/mco2.702.
A Molecular Hypothesis on Malignant Transformation of Oral Lichen Planus: A Systematic Review and Meta-Analysis of Cancer Hallmarks Expression in This Oral Potentially Malignant Disorder.
Keim-Del Pino C, Ramos-Garcia P, Gonzalez-Moles M
Cancers (Basel). 2024; 16(15).
PMID: 39123342
PMC: 11311016.
DOI: 10.3390/cancers16152614.
Tumor-associated genetic amplifications impact extracellular vesicle miRNA cargo and their recruitment of nerves in head and neck cancer.
Restaino A, Walz A, Barclay S, Fettig R, Vermeer P
FASEB J. 2024; 38(13):e23803.
PMID: 38963404
PMC: 11262563.
DOI: 10.1096/fj.202400625RR.
Identifying factors related to delayed neck metastasis after surgical treatment in patients with oral squamous cell carcinoma.
Lee S, Kim H, Ahn K
Maxillofac Plast Reconstr Surg. 2024; 46(1):21.
PMID: 38884878
PMC: 11183026.
DOI: 10.1186/s40902-024-00430-z.
Field Cancerization in Action; A Case of Synchronous Triple Primary Malignancies in the Head and Neck.
Lakshmanan J, Kushwaha A, Raja K, G S
Indian J Otolaryngol Head Neck Surg. 2024; 76(3):2817-2819.
PMID: 38883501
PMC: 11169135.
DOI: 10.1007/s12070-024-04522-0.
Molecular characterization of the evolution of premalignant lesions in the upper aerodigestive tract.
Lechner A, Kumbrink J, Walz C, Jung A, Baumeister P, Flach S
Front Oncol. 2024; 14:1364958.
PMID: 38706595
PMC: 11067708.
DOI: 10.3389/fonc.2024.1364958.
Navigating therapeutic strategies: HPV classification in head and neck cancer.
Tabatabaeian H, Bai Y, Huang R, Chaurasia A, Darido C
Br J Cancer. 2024; 131(2):220-230.
PMID: 38643337
PMC: 11263586.
DOI: 10.1038/s41416-024-02655-1.
p16 Expression in Laryngeal Squamous Cell Carcinoma: A Surrogate or Independent Prognostic Marker?.
Gallus R, Rizzo D, Rossi G, Mureddu L, Galli J, Artuso A
Pathogens. 2024; 13(2).
PMID: 38392838
PMC: 10892421.
DOI: 10.3390/pathogens13020100.
Promoter DNA methylation patterns in oral, laryngeal and oropharyngeal anatomical regions are associated with tumor differentiation, nodal involvement and survival.
Rivera-Pena B, Folawiyo O, Turaga N, Rodriguez-Benitez R, Felici M, Aponte-Ortiz J
Oncol Lett. 2024; 27(3):89.
PMID: 38268779
PMC: 10804364.
DOI: 10.3892/ol.2024.14223.